Dana L Buchanan, DO - Medicare Emergency Medicine in Modesto, CA

Dana L Buchanan, DO is a medicare enrolled "Emergency Medicine" physician in Modesto, California. She went to Philadelphia College Of Osteopathic Medicine and graduated in 2003 and has 21 years of diverse experience with area of expertise as Emergency Medicine. She is a member of the group practice Cep America - California, Golden Valley Health Center and her current practice location is 1441 Florida Ave, Modesto, California. You can reach out to her office (for appointments etc.) via phone at (209) 578-1211.

Dana L Buchanan is licensed to practice in California (license number 20A9469) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1174539423.

Contact Information

Dana L Buchanan, DO
1441 Florida Ave,
Modesto, CA 95350-4405
(209) 578-1211
Not Available



Physician's Profile

Full NameDana L Buchanan
GenderFemale
SpecialityEmergency Medicine
Experience21 Years
Location1441 Florida Ave, Modesto, California
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dana L Buchanan attended and graduated from Philadelphia College Of Osteopathic Medicine in 2003
  NPI Data:
  • NPI Number: 1174539423
  • Provider Enumeration Date: 07/31/2006
  • Last Update Date: 01/31/2008
  Medicare PECOS Information:
  • PECOS PAC ID: 8325041791
  • Enrollment ID: I20060824000578

Medical Identifiers

Medical identifiers for Dana L Buchanan such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1174539423NPI-NPPES
00AX94690MedicaidCA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207P00000XEmergency Medicine 20A9469 (California)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Memorial Medical CenterModesto, CAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Cep America - California6103739131954
Golden Valley Health Center418352718765

News Archive

Palatin Technologies completes first cohort dosing in bremelanotide trial for sexual dysfunction

Palatin Technologies, Inc. today announced the completion of first cohort dosing in a placebo-controlled, multiple dose study of bremelanotide, its experimental treatment for sexual dysfunction. The primary endpoint in this double-blind safety study is evaluation of blood pressure effects of subcutaneous bremelanotide in men between 45 and 65 years old. The study will also evaluate consistency of plasma exposure of bremelanotide given as repeated subcutaneous injections.

C-Path and FARA announce launch of Friedreich's Ataxia Integrated Clinical Database

Critical Path Institute's Data Collaboration Center and the Friedreich's Ataxia Research Alliance today announced the launch of the Friedreich's Ataxia Integrated Clinical Database.

Study: hGH linked to PROLOR's CTP technology increases half-life, bioactivity

PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today reported publication of a preclinical study in the current on-line edition of the journal Endocrinology showing that human growth hormone (hGH) linked to PROLOR's carboxyl terminal peptide (CTP) technology has significantly increased half-life and bioactivity compared to commercially available hGH. The publication, which is authored by PROLOR researchers, will also be included in the September print edition of Endocrinology.

New head-mounted display system lets anesthesiologists focus on monitoring data during surgery

A new head-mounted display system lets anesthesiologists keep an eye on critical monitoring data during surgery—without having to turn their attention away from the patient, reports a study in the April issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

Stroke researchers have traced the major cause of the death of brain cells

In the neurological train wreck that is stroke, researchers have traced the major cause of the death of brain cells due to artery blockage or bleeding in the brain.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dana L Buchanan allows following entities to bill medicare on her behalf.
Entity NameCep America - California
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1023063542
PECOS PAC ID: 6103739131
Enrollment ID: O20031106000520

News Archive

Palatin Technologies completes first cohort dosing in bremelanotide trial for sexual dysfunction

Palatin Technologies, Inc. today announced the completion of first cohort dosing in a placebo-controlled, multiple dose study of bremelanotide, its experimental treatment for sexual dysfunction. The primary endpoint in this double-blind safety study is evaluation of blood pressure effects of subcutaneous bremelanotide in men between 45 and 65 years old. The study will also evaluate consistency of plasma exposure of bremelanotide given as repeated subcutaneous injections.

C-Path and FARA announce launch of Friedreich's Ataxia Integrated Clinical Database

Critical Path Institute's Data Collaboration Center and the Friedreich's Ataxia Research Alliance today announced the launch of the Friedreich's Ataxia Integrated Clinical Database.

Study: hGH linked to PROLOR's CTP technology increases half-life, bioactivity

PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today reported publication of a preclinical study in the current on-line edition of the journal Endocrinology showing that human growth hormone (hGH) linked to PROLOR's carboxyl terminal peptide (CTP) technology has significantly increased half-life and bioactivity compared to commercially available hGH. The publication, which is authored by PROLOR researchers, will also be included in the September print edition of Endocrinology.

New head-mounted display system lets anesthesiologists focus on monitoring data during surgery

A new head-mounted display system lets anesthesiologists keep an eye on critical monitoring data during surgery—without having to turn their attention away from the patient, reports a study in the April issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

Stroke researchers have traced the major cause of the death of brain cells

In the neurological train wreck that is stroke, researchers have traced the major cause of the death of brain cells due to artery blockage or bleeding in the brain.

Read more Medical News

› Verified 6 days ago

Entity NameGolden Valley Health Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1356445753
PECOS PAC ID: 4183527187
Enrollment ID: O20040128000641

News Archive

Palatin Technologies completes first cohort dosing in bremelanotide trial for sexual dysfunction

Palatin Technologies, Inc. today announced the completion of first cohort dosing in a placebo-controlled, multiple dose study of bremelanotide, its experimental treatment for sexual dysfunction. The primary endpoint in this double-blind safety study is evaluation of blood pressure effects of subcutaneous bremelanotide in men between 45 and 65 years old. The study will also evaluate consistency of plasma exposure of bremelanotide given as repeated subcutaneous injections.

C-Path and FARA announce launch of Friedreich's Ataxia Integrated Clinical Database

Critical Path Institute's Data Collaboration Center and the Friedreich's Ataxia Research Alliance today announced the launch of the Friedreich's Ataxia Integrated Clinical Database.

Study: hGH linked to PROLOR's CTP technology increases half-life, bioactivity

PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today reported publication of a preclinical study in the current on-line edition of the journal Endocrinology showing that human growth hormone (hGH) linked to PROLOR's carboxyl terminal peptide (CTP) technology has significantly increased half-life and bioactivity compared to commercially available hGH. The publication, which is authored by PROLOR researchers, will also be included in the September print edition of Endocrinology.

New head-mounted display system lets anesthesiologists focus on monitoring data during surgery

A new head-mounted display system lets anesthesiologists keep an eye on critical monitoring data during surgery—without having to turn their attention away from the patient, reports a study in the April issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

Stroke researchers have traced the major cause of the death of brain cells

In the neurological train wreck that is stroke, researchers have traced the major cause of the death of brain cells due to artery blockage or bleeding in the brain.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dana L Buchanan is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dana L Buchanan, DO
2100 Powell St, Suite 900,
Emeryville, CA 94608-1826

Ph: (510) 350-2777
Dana L Buchanan, DO
1441 Florida Ave,
Modesto, CA 95350-4405

Ph: (209) 578-1211

News Archive

Palatin Technologies completes first cohort dosing in bremelanotide trial for sexual dysfunction

Palatin Technologies, Inc. today announced the completion of first cohort dosing in a placebo-controlled, multiple dose study of bremelanotide, its experimental treatment for sexual dysfunction. The primary endpoint in this double-blind safety study is evaluation of blood pressure effects of subcutaneous bremelanotide in men between 45 and 65 years old. The study will also evaluate consistency of plasma exposure of bremelanotide given as repeated subcutaneous injections.

C-Path and FARA announce launch of Friedreich's Ataxia Integrated Clinical Database

Critical Path Institute's Data Collaboration Center and the Friedreich's Ataxia Research Alliance today announced the launch of the Friedreich's Ataxia Integrated Clinical Database.

Study: hGH linked to PROLOR's CTP technology increases half-life, bioactivity

PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today reported publication of a preclinical study in the current on-line edition of the journal Endocrinology showing that human growth hormone (hGH) linked to PROLOR's carboxyl terminal peptide (CTP) technology has significantly increased half-life and bioactivity compared to commercially available hGH. The publication, which is authored by PROLOR researchers, will also be included in the September print edition of Endocrinology.

New head-mounted display system lets anesthesiologists focus on monitoring data during surgery

A new head-mounted display system lets anesthesiologists keep an eye on critical monitoring data during surgery—without having to turn their attention away from the patient, reports a study in the April issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

Stroke researchers have traced the major cause of the death of brain cells

In the neurological train wreck that is stroke, researchers have traced the major cause of the death of brain cells due to artery blockage or bleeding in the brain.

Read more News

› Verified 6 days ago


Emergency Medicine Doctors in Modesto, CA

John Joseph Gallo, M.D.
Emergency Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 3800 Dale Rd, Modesto, CA 95356
Phone: 209-557-1000    
Pallavi Sharma, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 600 Coffee Rd, Modesto, CA 95355
Phone: 209-521-6097    
Phillip Michael Chan, M.D.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1441 Florida Ave, Emergency Department, Modesto, CA 95350
Phone: 650-388-6383    
Dr. Paul Anthony Raykov, M.D.
Emergency Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 4601 Dale Rd, Modesto, CA 95356
Phone: 209-735-5000    
Gregory P. Bowerman, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1700 Coffee Rd, Modesto, CA 95355
Phone: 209-569-7600    
Christopher Samuel Lau, M.D.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 4601 Dale Rd, Modesto, CA 95356
Phone: 209-735-6810    
Sushma V Shah, MD
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 4301 N Star Way, Modesto, CA 95356
Phone: 209-342-2300    Fax: 209-524-4240

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.